OTCMKTS:GALNF Galenica (GALNF) Stock Price, News & Analysis → AI finds its first serious application (From Wall Street Star) (Ad) Free GALNF Stock Alerts C$75.25 0.00 (0.00%) (As of 02/15/2024) Add Compare Share Share Today's RangeC$75.25▼C$75.2550-Day RangeC$75.25▼C$75.2552-Week RangeC$75.25▼C$75.25Volume305 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartShort InterestStock AnalysisAnalyst ForecastsChartShort Interest Get Galenica alerts: Email Address Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details About Galenica Stock (OTCMKTS:GALNF)Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers master data system for the healthcare market; develops management solutions for the healthcare market; group internal IT services; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.Read More GALNF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GALNF Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive GALNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Galenica and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Distribution Sub-IndustryN/A Current SymbolOTCMKTS:GALNF CUSIPN/A CIKN/A Webwww.galenica.com Phone41 58 852 81 11FaxN/AEmployees4,459Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Marc Werner (Age 57)Chief Executive Officer Comp: $911.04kMr. Felix Burkhard (Age 58)CFO & Head of Investor Relations Ms. Barbara Walchli (Age 43)General Counsel & Secretary of the Board of Directors Mr. Iris Muller (Age 41)Head of Corporate Communications Dr. Thomas F. Szuran (Age 57)Chief Products & Marketing Officer Ms. Arianne Hasler (Age 45)Chief People & Culture Dr. Jörg Kneubühler (Age 64)Advisor Comp: $221.99kMr. Daniele Madonna (Age 47)Chief Healthcare Officer Mr. Andreas Koch (Age 53)Head of Wholesale & Logistics Ms. Virginie Pache Jeschka (Age 45)Chief Pharmacies Officer More ExecutivesKey CompetitorsAlfresaOTC:ARHCFArjo AB (publ)OTCMKTS:ARRJFEBOS GroupOTCMKTS:EBOSFMcKesson EuropeOTCMKTS:CAKFYMediosOTCMKTS:MEDOFView All Competitors GALNF Stock Analysis - Frequently Asked Questions Should I buy or sell Galenica stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Galenica in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" GALNF shares. View GALNF analyst ratings or view top-rated stocks. How have GALNF shares performed in 2024? Galenica's stock was trading at C$75.25 at the beginning of the year. Since then, GALNF shares have increased by 0.0% and is now trading at C$75.25. View the best growth stocks for 2024 here. Are investors shorting Galenica? Galenica saw a drop in short interest in April. As of April 15th, there was short interest totaling 43,800 shares, a drop of 5.4% from the March 31st total of 46,300 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days. View Galenica's Short Interest. How do I buy shares of Galenica? Shares of GALNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:GALNF) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTruth about Trump you’ve never heardPorter & CompanyProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galenica AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.